Quantitative in vitro studies on noradrenaline uptake and its inhibition by amphetamine, desipramine and chlorpromazine.
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology*; D003891:Desipramine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D009435:Synaptic Transmission; D014649:Vas Deferens / Q000378:metabolism
D012110:Reserpine; D000661:Amphetamine; D009526:Nialamide; D003891:Desipramine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine